Location History:
- Norristown, PA (US) (1997)
- Schweulisville, PA (US) (1998)
Company Filing History:
Years Active: 1997-1998
Title: Gordon Jacobs: Innovator in Cardiomyoplasty Technology
Introduction
Gordon Jacobs is a notable inventor based in Norristown, PA (US), recognized for his contributions to the field of cardiomyoplasty. With a total of 3 patents, Jacobs has made significant advancements in the control of muscle stimulation and heart performance.
Latest Patents
Jacobs' latest patents include innovative technologies aimed at improving cardiomyoplasty systems. One of his key inventions is the "Myostimulator control using metabolic demand and muscle performance." This patent describes a rate-responsive implantable device that controls the stimulation of both the heart and a myoplasty muscle. The device adjusts stimulation based on metabolic demand, ensuring that if the muscle is fatigued, its stimulation is maintained or reduced while cardiac stimulation compensates for increased demand. Another significant patent is the "Cardiomyoplasty simulator with feedback control," which utilizes a closed-loop control system to electronically stimulate a cardiomyoplastic muscle. This system monitors the muscle's condition and modifies stimulation in response to any abnormal signals detected.
Career Highlights
Throughout his career, Gordon Jacobs has worked with prominent companies in the medical technology sector, including Pacesetter, Inc. and Telectronics Pacing Systems, Inc. His work has focused on developing advanced solutions for heart and muscle stimulation, contributing to improved patient outcomes in cardiomyoplasty.
Collaborations
Jacobs has collaborated with several professionals in his field, including Tuan S Bui and Stuart B McConchie. These collaborations have likely enhanced the innovation and effectiveness of his inventions.
Conclusion
Gordon Jacobs stands out as an influential inventor in the realm of cardiomyoplasty technology. His patents reflect a commitment to advancing medical devices that enhance heart and muscle performance, ultimately benefiting patients in need of such innovations.